Effect of chronic treatment with tricyclic antidepressant drugs on identified brain noradrenergic and serotonergic neurons.
D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects*; D002997:Clomipramine / Q000494:pharmacology; D003000:Clonidine / Q000494:pharmacology; D004347:Drug Interactions; D007099:Imipramine / Q000494:pharmacology; D007478:Iontophoresis; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008297:Male; D009474:Neurons / Q000187:drug effects*; D009638:Norepinephrine / Q000378:metabolism; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects*; D011985:Receptors, Serotonin / Q000187:drug effects*; D015016:Yohimbine / Q000494:pharmacology
D000929:Antidepressive Agents, Tricyclic; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D011985:Receptors, Serotonin; D015016:Yohimbine; D008238:Lysergic Acid Diethylamide; D011433:Propranolol; D003000:Clonidine; D002997:Clomipramine; D007099:Imipramine; D009638:Norepinephrine